Literature DB >> 28674697

Cell-free vascular grafts: Recent developments and clinical potential.

Sindhu Row1,2, Ana Santandreu1, Daniel D Swartz2, Stelios T Andreadis1,3,4,2.   

Abstract

Recent advances in vascular tissue engineering have led to the development of cell-free grafts that are available off-the-shelf for on demand surgery. Challenges associated with cell-based technologies including cell sourcing, cell expansion and long-term bioreactor culture motivated the development of completely cell-free vascular grafts. These are based on decellularized arteries, decellularized cultured cell-based tissue engineered grafts or biomaterials functionalized with biological signals that promote in situ tissue regeneration. Clinical trials undertaken to demonstrate the applicability of these grafts are also discussed. This comprehensive review summarizes recent developments in vascular graft technologies, with potential applications in coronary artery bypass procedures, lower extremity bypass, vascular injury and trauma, congenital heart diseases and dialysis access shunts, to name a few.

Entities:  

Keywords:  Cardiovascular Disease; Decellularization; Functionalized Biomaterials; In Situ Tissue Regeneration; Tissue Engineering; Vascular Grafts

Year:  2017        PMID: 28674697      PMCID: PMC5492388          DOI: 10.1142/S2339547817400015

Source DB:  PubMed          Journal:  Technology (Singap World Sci)


  95 in total

Review 1.  Decellularized biological matrices: an interesting approach for cardiovascular tissue repair and regeneration.

Authors:  Francesca Boccafoschi; Margherita Botta; Luca Fusaro; Francesco Copes; Martina Ramella; Mario Cannas
Journal:  J Tissue Eng Regen Med       Date:  2015-10-29       Impact factor: 3.963

2.  Blood vessels engineered from human cells.

Authors:  Melissa Poh; Matthew Boyer; Amy Solan; Shannon L M Dahl; Dawn Pedrotty; Soma S R Banik; J Andrew McKee; Rebecca Y Klinger; Christopher M Counter; Laura E Niklason
Journal:  Lancet       Date:  2005 Jun 18-24       Impact factor: 79.321

3.  Immobilization of glycoproteins, such as VEGF, on biodegradable substrates.

Authors:  J L Sharon; D A Puleo
Journal:  Acta Biomater       Date:  2008-03-05       Impact factor: 8.947

4.  Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels.

Authors:  P B Canham; H M Finlay; D R Boughner
Journal:  Cardiovasc Res       Date:  1997-06       Impact factor: 10.787

5.  Co-electrospun nanofiber fabrics of poly(L-lactide-co-epsilon-caprolactone) with type I collagen or heparin.

Authors:  Il Keun Kwon; Takehisa Matsuda
Journal:  Biomacromolecules       Date:  2005 Jul-Aug       Impact factor: 6.988

6.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Authors:  Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-05       Impact factor: 11.205

Review 7.  Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.

Authors:  Soo-Hyun Kim; Jeremy Turnbull; Scott Guimond
Journal:  J Endocrinol       Date:  2011-02-09       Impact factor: 4.286

8.  Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons.

Authors:  P A Schneider; S R Hanson; T M Price; L A Harker
Journal:  J Vasc Surg       Date:  1988-09       Impact factor: 4.268

9.  Composite vascular grafts with high cell infiltration by co-electrospinning.

Authors:  Zhikai Tan; Hongjie Wang; Xiangkai Gao; Tong Liu; Yongjun Tan
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-05-16       Impact factor: 7.328

10.  Patency in canine inferior vena cava grafting: effects of graft material, size, and endothelial seeding.

Authors:  M Herring; A Gardner; P Peigh; D Madison; S Baughman; J Brown; J Glover
Journal:  J Vasc Surg       Date:  1984-11       Impact factor: 4.268

View more
  4 in total

1.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

Review 2.  In Vivo Performance of Decellularized Vascular Grafts: A Review Article.

Authors:  Chih-Hsun Lin; Kai Hsia; Hsu Ma; Hsinyu Lee; Jen-Her Lu
Journal:  Int J Mol Sci       Date:  2018-07-19       Impact factor: 5.923

Review 3.  Decellularized blood vessel development: Current state-of-the-art and future directions.

Authors:  Xinyu Wang; Vincent Chan; Peter R Corridon
Journal:  Front Bioeng Biotechnol       Date:  2022-08-08

Review 4.  Aortic "Disease-in-a-Dish": Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling.

Authors:  Hongorzul Davaapil; Deeti K Shetty; Sanjay Sinha
Journal:  Front Cell Dev Biol       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.